Arrowhead PharmaceuticalsARWR
那斯達克 · USD
15.73
-0.08
(-0.47%)
盤中 08/02 01:00 (UTC+8)
08/02 01:00 (UTC+8)
Arrowhead PharmaceuticalsARWR
15.73
-0.08
(-0.47%)
財務數據
損益表
- 0.63
- 1.46
- 0.16
- 0.16
- 0.04
- -
- -
- -
- 0.03
- 5.43
- 98.09
- 133.86
- -89.18
- 1.72
- -77.94
- -
- -
- -
- -
- 21608.36
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 542,709 | 2,500 | - | - | - | 3,551 | 16,097 | 15,825 | 146,267 | 62,546 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 542,709 | 2,500 | - | - | - | 3,551 | 16,097 | 15,825 | 146,267 | 62,546 |
營業費用 | - | 163,912 | - | 176,141 | 126,191 | 140,096 | 124,427 | 118,528 | 98,102 | 104,680 |
研發費用 | 133,102 | 137,002 | 135,826 | 152,431 | 101,122 | 116,491 | 99,855 | 94,757 | 74,881 | 83,695 |
推銷及管理費用 | 28,405 | 26,910 | 26,377 | 23,710 | 25,069 | 23,605 | 24,572 | 23,771 | 23,221 | 20,985 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 381,202 | -161,412 | -162,203 | -176,141 | -126,191 | -136,545 | -108,330 | -102,703 | 48,165 | -42,134 |
其他收入及費用 | 10,053 | 7,943 | 4,052 | 7,258 | 6,439 | 3,223 | 4,602 | 4,478 | 4,568 | 507 |
利息費用 | 21,639 | 21,646 | 14,647 | 5,094 | 7,244 | 5,367 | 5,262 | 5,158 | 5,057 | - |
稅前純益 | 369,616 | -175,115 | -172,798 | -173,977 | -126,996 | -138,689 | -108,990 | -103,383 | 47,676 | -41,794 |
所得稅 | 1,753 | 103 | 546 | - | - | -3,313 | 2,025 | 742 | - | 17 |
稅後純益 | 370,445 | -173,085 | -170,536 | -170,793 | -125,300 | -132,864 | -109,679 | -102,946 | 48,675 | -41,325 |
基本每股稅後盈餘(元) | 2.78 | -1.39 | -1.36 | -1.38 | -1.02 | -1.24 | - | -0.96 | 0.46 | -0.39 |
稀釋每股稅後盈餘(元) | 2.91 | -1.39 | -1.37 | -1.39 | -1.00 | -1.24 | -1.02 | -0.97 | 0.46 | -0.39 |
基本平均股數(千股) | 133363.00 | 124848.00 | 124237.00 | 124199.00 | 123285.00 | 107415.00 | - | 107004.00 | 106757.00 | 106039.00 |
稀釋平均股數(千股) | 134484.00 | 124848.00 | 124237.00 | 124199.00 | 123285.00 | 107415.00 | - | 107004.00 | 108143.00 | 106039.00 |
還原基本每股稅後盈餘(元) | 2.78 | -1.39 | -1.36 | -1.38 | -1.02 | -1.24 | - | -0.96 | 0.46 | -0.39 |
還原稀釋每股稅後盈餘(元) | 2.91 | -1.39 | -1.37 | -1.39 | -1.00 | -1.24 | -1.02 | -0.97 | 0.46 | -0.39 |
還原基本平均股數(千股) | 133,363 | 124,848 | 124,237 | 124,199 | 123,285 | 107,415 | - | 107,004 | 106,757 | 106,039 |
還原稀釋平均股數(千股) | 134,484 | 124,848 | 124,237 | 124,199 | 123,285 | 107,415 | - | 107,004 | 108,143 | 106,039 |
EBITDA(千元) | 402,837 | -151,805 | -161,448 | -153,927 | -111,800 | -127,382 | -99,520 | -94,718 | 55,629 | -37,929 |